Sepsis

The type of arteriovenous access placement, graft or fistula, used first in older patients receiving hemodialysis did not impact their risk for death, sepsis or hospitalization.

Oral corticosteroid bursts were associated with a 1.4- to 2.2-fold increased risk for gastrointestinal bleeding, sepsis and pneumonia among children within the first month after use, according to study results published in JAMA Pediatrics.

Pulmonary dysfunction and septic shock were the most common causes of death in a cohort of patients hospitalized with COVID-19, according to a new study published in the Annals of the American Thoracic Society.

A healthy 12-day old female seems to suddenly develop painless bilateral swelling of both the preauricular areas and the right postauricular area. There is no fever or other concerning symptoms, and her appetite is normal and unchanged.

Sepsis has surpassed pneumonia as the most common hospitalized infection in systemic lupus erythematosus, with a rate that has increased more than six-fold from 1998 to 2000 to 2015 to 2016, according to data published in Arthritis & Rheumatology.

Multiple underlying risk factors, such as IV drug use, and increased mortality rates were found in patients with native shoulder joint sepsis who are treated with surgical irrigation and debridement, according to recently presented results.

The rate of hospitalizations due to serious infection in patients with vasculitis nearly doubled over a 19-year period, according to data published in Arthritis Care & Research.

Recent data from a multinational randomized control trial showed the investigational antiviral remdesivir reduced the time to recovery from COVID-19. It was the top story in infectious disease last week.

Stenotrophomonas maltophili a was unexpectedly identified as the most common carbapenem-resistant, gram-negative pathogen to cause bloodstream infections between 2010 and 2015 in a retrospective cohort study of a large U.S. database.

Cytovale Inc. will expand its partnership with the Biomedical Advanced Research and Development Authority, or BARDA, to examine the use of Cytovale’s Rapid Sepsis Diagnostic System for diagnosing sepsis in patients with potential respiratory infections, including COVID-19, according to a press release.